Burzynski Research Institute Inc Sustainability Reports
The company engages in the research, production, and clinical testing of medical chemical compounds known as Antineoplastons, which are being investigated for the treatment of various human cancers.
Sector: Manufacturing
Country: United States
Exchange: OTC Markets
FIGI: BBG001S6YD16
No reports are currently available in our catalogue.